Breast cancer detection has 4 findings that explain why early screening changes everything
Breast cancer detection is the medical conversation that most women know they should be having more seriously than they are. The recommendations exist, the technology exists, and the evidence for why early detection changes outcomes is among the most well-established in all of oncology. And yet screening rates remain below where public health researchers believe […]
COCOON trial shows that proactive skin care could be a game changer for lung cancer patients
COCOON trial findings are reshaping how oncologists think about managing one of the most common and disruptive side effects of modern lung cancer therapy. A new research commentary published in the journal Oncoscience summarizes interim results from a phase II clinical trial that tested whether a structured preventive skin care approach could reduce the dermatologic […]
Revolutionizing liver cancer screening with AI tools
Liver cancer is one of medicine’s more frustrating diagnostic problems. By the time most patients receive a diagnosis, the disease has already progressed to a stage where treatment options narrow considerably. A new study suggests that artificial intelligence may be able to change that timeline in a meaningful way. Researchers have developed a machine learning […]
Cancer rates are surging in unexpected places and the NCCN conference just exposed why
Cancer is no longer waiting for old age. That uncomfortable reality set the tone at one of the most significant annual gatherings in oncology, where more than a thousand cancer care professionals came together in Orlando, Florida, to confront some of the most pressing challenges facing the field today. The NCCN 2026 Annual Conference brought […]
Lymphoma symptoms are easy to dismiss and that is exactly what makes them so dangerous
Hodgkin lymphoma is one of the two main types of lymphoma, a cancer that develops in the lymphatic system, which forms a critical part of the body’s immune defenses. Though less commonly discussed than non-Hodgkin lymphoma, it is far from rare. The American Cancer Society estimates nearly 9,000 new cases will be diagnosed this year […]
Merck $5.7bn deal targets bone and blood cancer
Merck is making yet another major move in the pharmaceutical world. The New Jersey-based drugmaker has agreed to acquire Terns Pharmaceuticals, a California-based biotech developing a promising treatment for a rare and life-threatening form of blood and bone cancer and the deal is worth $5.7 billion. The announcement, made Wednesday, signals just how aggressively Merck […]
New study reveals promising treatment for cervical cancer
Cervical cancer remains a significant health concern, accounting for approximately 4,000 deaths annually in the United States alone. Recent advancements in treatment strategies are crucial, especially considering that up to 30% of patients may experience a recurrence within five years of treatment. A groundbreaking phase 3 clinical trial has shed light on a potentially more […]